openPR Logo
Press release

Clostridium Vaccine (Animal Health) Market: Trends and Opportunities for the Industry by 2024

09-18-2017 09:12 AM CET | Health & Medicine

Press release from: Transparency Market Research

Clostridium Vaccine Market

Clostridium Vaccine Market

The global clostridium vaccines market will exhibit a healthy 4.9% CAGR over the period between 2016 and 2024. Rising at this rate, the market, which valued at US$418.0 mn in 2015, is expected to reach US$643.5 mn by 2024. In terms of animal species, the swine segment presently leads but is expected to be outpaced by the growth of the ovine segment. In terms of geography, the global market is dominated by North America, which accounted for over 37% of the global market in 2015.

Government initiatives play a key role the development of animal health care markets. For instance, the China market for veterinary healthcare is chiefly driven by compulsory immunization policy, several animal health awareness programs, the easy availability of affordable veterinary vaccines, and fund for research and development in the field. In several other developed as well as developing economies, funds invested by government bodies for the research and development of veterinary vaccines and medications play a key role in boosting the demand for clostridium vaccines.

Along with this, the rising global demand for animal products such as cattle milk, meat, and eggs is also a key factor driving the global market for clostridium vaccines. Animal products such as milk, pork, beef, and chicken collectively account for nearly 40% of global agricultural GDP and generated revenues valuing nearly US$600 bn in 2015. The market for these products in developing countries is growing rapidly due to the rising population and increased disposable incomes. The resultant rise in awareness regarding the need for maintaining the excellent health of animals is expected to further drive the clostridium vaccines market in the near future.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16682

In emerging economies, especially, government bodies play the central role in the distribution of vaccines. The Government of India, for instance, buys clostridium vaccines in bulk from manufacturers and supply them in different regions of the country. Bulk purchase of clostridium vaccines results in reduced prices, resulting in the low profitability of the market thus hampering its overall rate of development.

Moreover, the market's growth is also restrained to vast extent owing to the short exclusivity span of clostridium vaccines. Product exclusivity period in the animal health care industry is mostly only about three years to five years. Shorter exclusivity periods lead to a vast rise in competition from generics and over-the-counter (OTC) products. The increase in generic competition lowers product sales and significantly affects the profitability of the market.

Request to Download TOC of the Report: http://www.transparencymarketresearch.com/report-toc/16682

The global clostridium vaccine (animal health) market features a largely consolidated competitive landscape, with the top five companies collectively accounting for a share of over 63% of the overall market in 2015, observes a recent report by Transparency Market Research (TMR). These top vendors, namely Zoetis, Inc., Merck & Co., Sanofi-Aventis, Boehringer Ingelheim, and Eli Lilly and Company hold commanding positions owing to their wide geographic presence and a strong financial backing allowing increased focus on research and development activities.

Top companies in the market aim to strengthen their positions with strategies such as targeted in-licensing, acquisition, and innovative marketing. Use of the digital medium to reach out to an extended consumer base and serve the consumer more effectively has also started becoming a popular strategy. An instance is the recent update made to Bayer’s BCS cowdition smartphone application in July 2016. The enhanced application is expected to help veterinarians to track the current and future hurdles regarding cattle health, which will help minimize the impact of metabolic diseases on dairy cows.

Global Clostridium Vaccine (Animal Health) Market Report is available @ US$ 5795 : http://www.transparencymarketresearch.com/checkout.php?rep_id=16682<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clostridium Vaccine (Animal Health) Market: Trends and Opportunities for the Industry by 2024 here

News-ID: 721869 • Views: 111

More Releases from Transparency Market Research

Food Premix Market Observe Substantial Growth by 2018-2026
Global Food Premix Market: Overview Globally, the parents are more conscious about their baby food. They prefer to give healthy and high nutritional content to their babies. This has led the demand in the global food premix market Read report Overview- https://www.transparencymarketresearch.com/food-premix-market.html Based on form and application are likely to be the key segments in which the market can be divided. Food & beverages, early life nutrition/ baby food, pharma OTC drugs, dietary supplements,
Calcium Silicate Market with Positive Long-Term Growth Outlook, 2016-2023
Calcium silicate, also known as calcium orthosilicate, is a white powder derived from diatomaceous earth and limestone. It is obtained by reacting calcium oxide and silica in various ratios. Calcium silicate possesses properties such as high physical water absorption and low bulk density. Due to these special physical characteristics calcium silicate has several applications in the construction sector. It is also used as a food additive in the food processing
Polysulfides Market Scope and Opportunities Analysis 2015– 2023
Polysulfides are chemical compounds that primarily comprise chains of sulfur atoms. These compounds exhibit various functional properties due to which they are chiefly consumed in building & construction, marine, aerospace, glass insulation, and polymer processing industries. Polysulfides possess high flexibility, high tensile strength, impermeability, chemical and weather resistance, and heat insulation. Read report Overview- https://www.transparencymarketresearch.com/polysulfides-market.html Hence, they are favorably used in coating and sealing applications. These sulfur compounds are generally classified as anionic
CRISPR and Cas Genes Market Compnies Size, Future Trends, Segmentation, Gross Ma …
Transparency Market Research (TMR) has published a new report titled, “CRISPR and Cas Genes Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global CRISPR and Cas genes market was valued at US$ 7,234.5 Mn by 2026, expanding at a CAGR of around 20.1% from 2018 to 2026. Increase in applications of CRISPR and Cas gene editing technology in bacteria and usage

All 5 Releases


More Releases for Clostridium

Clostridium Vaccine Market to Witness Robust Expansion by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Clostridium Vaccine market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/212021/global-clostridium-vaccine-market Global Clostridium Vaccine Market: Forecast by Type / Application / Region According to this study, over the next five years the Clostridium Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of
Collagenase Clostridium Histolyticum Market Trends, Analysis and Forecast 2016 - …
Global Collagenase Clostridium Histolyticum Market: Overview Collagenase clostridium histolyticum is primarily used in the treatment of Dupuytren’s contracture and Peyronie’s disease. Thus, the global market for collagenase clostridium histolyticum is gaining traction due to the rising prevalence of these two diseases, especially in developed countries. Request Brochure- https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4474 Collagenase is an enzyme that helps in breaking down the chord of thickened tissue and permits straightening of fingers. Some of the primary medications available in
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of
Clostridium Vaccine Market : Share, Analysis To 2024
The global clostridium vaccine (animal health) market features a largely consolidated competitive landscape, with the top five companies collectively accounting for a share of over 63% of the overall market in 2015, observes a recent report by Transparency Market Research (TMR). These top vendors, namely Zoetis, Inc., Merck & Co., Sanofi-Aventis, Boehringer Ingelheim, and Eli Lilly and Company hold commanding positions owing to their wide geographic presence and a strong
Clostridium Vaccine Market to Grow Exponentially
Global Clostridium Vaccines Market: Snapshot Clostridium vaccines are chiefly utilized for a variety of bovine and ovine clostridial diseases such as blackleg, pulpy kidney (enterotoxaemia), black disease, and tetanus. The demand for clostridium vaccine is rising globally owing to the increasing incidence rate of clostridium family diseases and increased awareness regarding zoonotic diseases. Rising concerns about the mortality of livestock animal and the socioeconomic impact of it on agrarian economies are